Arthritis drug Bextra found to promote heart attacks and strokes

Email this article to a friend

Printable Version

Articles Related to This Article: • Arthritis drug researchers apologize for undisclosed pharmaceutical industry ties • FDA whistleblower warns about safety of new arthritis drug Arcoxia • Rheumatoid Arthritis Drug Linked to Serious Infections and Cancers (press release) Sign the Health Revolution Petition Join the call for genuine health freedom in America. End FDA tyranny and Big Pharma corruption. Watch the video and sign the petition here.

Following the recent revelations that Vioxx cause a high incidence of heart attacks and strokes, a competing drug from Pfizer, Bextra, has now been shown to display similar health problems. What's especially weighty about this particular revelation is that it comes from the American Heart Association, a disease-industry group that has traditionally acted in favor of pharmaceutical companies. Because of this, the AHA deserves credit for allowing this study to be published.

In the preliminary results, Bextra was found to increase the incidence of heart attacks and strokes by 219%. The cardiologist who presented the study, Dr. Garret Fitzgerald, called Bextra, "A time bomb waiting to go off," and noted that the apparent dangers of Bextra exceed those associated with Vioxx.

Pfizer, of course, downplayed the study in an attempt to minimize any negative backlash from its release. The question remains, however: will Pfizer now follow in Merck's footsteps and voluntarily recall Bextra? And if it refuses to do so, will the FDA step in and finally perform the regulatory function it has been so reluctant to use by banning Bextra from the market? Or will this warning be swept aside in favor of a policy that allows this drug to continue to be sold to tens of millions of Americans, regardless of its questionable safety?
About the author: Mike Adams is a natural health author and technology pioneer with a passion for sharing empowering information to help improve personal and planetary health He has authored and published thousands of articles, interviews, consumers guides, and books on topics like health and the environment, reaching millions of readers with information that is saving lives and improving personal health around the world. Adams is a trusted, independent journalist who receives no money or promotional fees whatsoever to write about other companies' products. In 2007, Adams launched EcoLEDs, a maker of super bright LED light bulbs that are 1000% more energy efficient than incandescent lights. He also launched an online retailer of environmentally-friendly products (BetterLifeGoods.com) and uses a portion of its profits to help fund non-profit endeavors. He's also a noted pioneer in the email marketing software industry, having been the first to launch an HTML email newsletter technology that has grown to become a standard in the industry. Adams also serves as the executive director of the Consumer Wellness Center, a non-profit consumer protection group, and enjoys outdoor activities, nature photography, Pilates and adult gymnastics.


Get articles like this delivered to you FREE in our popular email newsletter

Related CounterThink Cartoons:

Related Articles: • Arthritis drug researchers apologize for undisclosed pharmaceutical industry ties • FDA whistleblower warns about safety of new arthritis drug Arcoxia • Rheumatoid Arthritis Drug Linked to Serious Infections and Cancers (press release)	Take Action: Support NaturalNews.com Email this article to a friend Share this article on: NewsVine | digg | del.icio.us Permalink to this article: http://www.NaturalNews.com/002348_arthritis_drug_Bextra_Pfizer.html Reprinting this article: Non-commercial use OK, cite NaturalNews.com with clickable link. Embed article link: (copy HTML code below): <a href = "http://www.NaturalNews.com/002348_arthritis_drug_Bextra_Pfizer.html">Arthritis drug Bextra found to promote heart attacks and strokes</a>